A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis
The DOI matches its Crossref record; 77 of the 78 references it cites were found in a registry or an index.
Abstract
Hereditary haemochromatosis (HH), which affects some 1 in 400 and has an estimated carrier frequency of 1 in 10 individuals of Northern European descent, results in multi-organ dysfunction caused by increased iron deposition, and is treatable if detected early. Using linkage-disequilibrium and full haplotype analysis, we have identified a 250-kilobase region more than 3 megabases telomeric of the major histocompatibility complex (MHC) that is identical-by-descent in 85% of patient chromosomes. Within this region, we have identified a gene related to the MHC class I family, termed HLA-H, containing two missense alterations. One of these is predicted to inactivate this class of proteins and was found homozygous in 83% of 178 patients. A role of this gene in haemochromatosis is supported by the frequency and nature of the major mutation and prior studies implicating MHC class I-like proteins in iron metabolism.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“HFE encodes an atypical MHC class I molecule which plays a major role in the regulation of iron homeostasis under basal conditions (Feder et al., 1996; Ludwiczek et al., 2004).”
From Genetic and Dietary Iron Overload Differentially Affect the Course of Salmonella Typhimurium Infection (2017) · cites this paper as Feder et al., 1996
In the citing paper
“Two decades later that insight led to the identification of HFE (originally called HLA-H), the gene mutated in the large majority of patients with hemochromatosis.121”
From Forging a field: the golden age of iron biology. (2008) · cites this paper as [121]
In the citing paper
“This mutation disrupts the formation of the disulfide bridge, which appears to be necessary for proper protein formation, causing the aberrant protein remains in the Golgi (24, 83).”
From Intracellular iron transport and storage: from molecular mechanisms to health implications (2008) · cites this paper as [83]
In the citing paper
“Normal HFE protein associates with TfR, usually in conjunction with β2-microglobulin, and competes with Tf for TfR binding, thereby inhibiting Fe-Tf uptake via the TfR in cells (83, 179).”
From Intracellular iron transport and storage: from molecular mechanisms to health implications (2008) · cites this paper as [83]
Citations
Cites
The Metabolic and Molecular Bases of Inherited Disease
Scriver, R. C. (1995) · Medical Entomology and Zoology · Cited by 12,101
Identification of the Cystic Fibrosis Gene: Genetic Analysis
Kerem, B.-S., Rommens, J. M., Buchanan, J. A., Markiewicz, D., Cox, T. K., Chakravarti, A., Buchwald, M., & Tsui, L.-C. (1989) · Science · doi:10.1126/science.2570460 · Cited by 4,142
Structure of the human class I histocompatibility antigen, HLA-A2
Bjorkman, P. J., Saper, M. A., Samraoui, B., Bennett, W. S., Strominger, J. L., & Wiley, D. C. (1987) · Nature · doi:10.1038/329506a0 · Cited by 3,472
Abundant class of human DNA polymorphisms which can be typed using the polymerase chain reaction.
Weber, J. L., & May, P. E. (1989) · Europe PMC (PubMed Central) · Cited by 3,399
A comprehensive genetic map of the human genome based on 5,264 microsatellites
Dib, C., Fauré, S., Fizames, C., Samson, D., Drouot, N., Vignal, A., Millasseau, P., Marc, S., Kazan, J., Seboun, E., et al. (1996) · Nature · doi:10.1038/380152a0 · Cited by 2,928
Shizuya, H., Birren, B., Kim, U. J., Mancino, V, Slepak, T., Tachiiri, Y., & Simon, M. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.18.8794 · Cited by 1,671
β2-Microglobulin deficient mice lack CD4−8+ cytolytic T cells
Zijlstra, M., Bix, M., Simister, N. E., Loring, J. M., Raulet, D. H., & Jaenisch, R. (1990) · Nature · doi:10.1038/344742a0 · Cited by 1,012
Current Protocols in Human Genetics
(2001) · John Wiley & Sons, Inc. eBooks · doi:10.1002/0471142905 · Cited by 987
Normal Development of Mice Deficient in β 2 M, MCClass I Proteins, and CD8 + T Cells
Koller, B. H., Marrack, P., Kappler, J. W., & Smithies, O. (1990) · Science · doi:10.1126/science.2112266 · Cited by 881
A new bacteriophage P1–derived vector for the propagation of large human DNA fragments
loannou, P. A., Amemiya, C. T., Garnes, J., Kroisel, P. M., Shizuya, H., Chen, C., Batzer, M. A., & de Jong, P. J. (1994) · Nature Genetics · doi:10.1038/ng0194-84 · Cited by 844
Research works printed but not linked: 1
- Hudson, T. et al. An STS-based map of the human genome. Science 270, 1945–1954, with supplementary data from the Whitehead Institute/MIT Center for Genome Research, human genetic mapping project, data release 10(May 1996) (1995). · DOI · Paper page
Cited by
Items 201–300 of 1,020
Iron deficiency in blood donors: the REDS‐II Donor Iron Status Evaluation (RISE) study
Cable, R. G., Glynn, S. A., Kiss, J. E., Mast, A. E., Steele, W. R., Murphy, E. L., Wright, D. J., Sacher, R. A., Gottschall, J. L., Tobler, L. H., et al. (2012) · Transfusion · doi:10.1111/j.1537-2995.2011.03401.x · Cited by 230
Tsukaguchi, H., Sudhakar, A., Le, T. C., Nguyen, T., Yao, J., Schwimmer, J. A., Schachter, A. D., Poch, E., Abreu, P. F., Appel, G. B., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci16242 · Cited by 234
“Similar carrier frequencies have been reported for well-known common diseases (Table 2), including ∆F508, and IVS8-5T in the cystic fibrosis gene CFTR (24, 25); C282Y in HFE in hemochromatosis (23); 30delG in GJB2 in nonsyndromic sensory deafness (26); and G2588C in ABCR in Stargardt disease (27).”
ResultFargion, S. (2001) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(01)02615-6 · Cited by 233
“A candidate gene for HHC encoding a human leukocyte antigen (HLA) class I-like molecule, HFE, has recently been identified”
BackgroundThe Spectrum of Achalasia: Lessons From Studies of Pathophysiology and High-Resolution Manometry
Kahrilas, P. J., & Boeckxstaens, G. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.08.038 · Cited by 235
Heterogeneity of hemochromatosis in Italy
Piperno, A., Sampietro, M., Pietrangelo, A., Arosio, C., Lupica, L., Montosi, G., Vergani, A., Fraquelli, M., Girelli, D., & Pasquero, P. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70319-1 · Cited by 235
Diferric transferrin regulates transferrin receptor 2 protein stability
Johnson, M. B., & Enns, C. A. (2004) · Blood · doi:10.1182/blood-2004-06-2477 · Cited by 227
Juvenile Hemochromatosis Locus Maps to Chromosome 1q
Roetto, A., Totaro, A., Cazzola, M., Cicilano, M., Bosio, S., D'Ascola, G., Carella, M., Zelante, L., Kelly, A. L., Cox, T. M., et al. (1999) · The American Journal of Human Genetics · doi:10.1086/302379 · Cited by 236
“Recent studies have shown that patients with JH (1) do not have mutations in the HFE gene that lead to HH (Feder et al. 1996) and (2) do not show linkage to 6p (Camaschella et al. 1997).”
BackgroundInfluentialSimpson, P. C., Roach, D., Woolley, A. T., Thorsen, T., Johnston, R., Sensabaugh, G. F., & Mathies, R. A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.5.2256 · Cited by 234
Reducing TMPRSS6 ameliorates hemochromatosis and β-thalassemia in mice
Guo, S., Casu, C., Gardenghi, S., Booten, S., Aghajan, M., Peralta, R., Watt, A., Freier, S., Monia, B. P., & Rivella, S. (2013) · Journal of Clinical Investigation · doi:10.1172/jci66969 · Cited by 222
“Mutations in the HFE gene are associated with the most frequent form of hereditary hemochromatosis, which results from a failure to upregulate HAMP and downregulate iron absorption despite an increased iron load (22, 23).”
A role of PIEZO1 in iron metabolism in mice and humans
Ma, S., Dubin, A. E., Zhang, Y., Mousavi, S. A. R., Wang, Y., Coombs, A. M., Loud, M., Andolfo, I., & Patapoutian, A. (2021) · Cell · doi:10.1016/j.cell.2021.01.024 · Cited by 232
“Mechanisms beyond HFE and transferrin pathway could contribute to iron metabolism deficiencies in humans.”
InfluentialTuomainen, T.-P., Kontula, K., Nyyssönen, K., Lakka, T. A., Heliö, T., & Salonen, J. T. (1999) · Circulation · doi:10.1161/01.cir.100.12.1274 · Cited by 232
Iron, Free Radicals, and Oxidative Injury
McCord, J. M. (2004) · The Journal of Nutrition · doi:10.1093/jn/134.11.3171s · Cited by 233
MR Quantification of Hepatic Iron Concentration
Alústiza, J. M., Artetxe, J., Castiella, A., Agirre, C., Emparanza, J. I., Otazua, P., García-Bengoechea, M., Barrio, J., Mújica, F., & Recondo, J. A. (2004) · Radiology · doi:10.1148/radiol.2302020820 · Cited by 228
TPMT in the treatment of Crohn's disease with azathioprine
Lennard, L. (2002) · Gut · doi:10.1136/gut.51.2.143 · Cited by 229
Prevalence of C282Y and H63D Mutations in the Hemochromatosis (HFE) Gene in the United States
Steinberg, K. K., Cogswell, M. E., Chang, J. C., Caudill, S. P., McQuillan, G. M., Bowman, B. A., Grummer-Strawn, L. M., Sampson, E. J., Khoury, M. J., & Gallagher, M. L. (2001) · JAMA · doi:10.1001/jama.285.17.2216 · Cited by 230
“Thehemochromatosisgene(HFE)has been localized to the short arm of chromosome 6 and has been identified as a major histocompatibility complex class I-like gene.(5) Recent evidence shows that the protein coded for by HFE binds to the transferrin receptor and reduces its affinity for iron-boundtransferrin.”
BackgroundInfluentialGenetic susceptibility to lead poisoning.
Onalaja, A. O., & Claudio, L. (2000) · Environmental Health Perspectives · doi:10.1289/ehp.00108s123 · Cited by 227
Role of L-type Ca2+ channels in iron transport and iron-overload cardiomyopathy
Oudit, G. Y., Trivieri, M. G., Khaper, N., Liu, P. P., & Backx, P. H. (2006) · Journal of Molecular Medicine · doi:10.1007/s00109-005-0029-x · Cited by 222
“63H → D [7, 168, 169]”
Gross, C. N., Irrinki, A., Feder, J. N., & Enns, C. A. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.34.22068 · Cited by 227
Self-citationHepcidin: regulation of the master iron regulator
Rishi, G., Wallace, D. F., & Subramaniam, V. N. (2015) · Bioscience Reports · doi:10.1042/bsr20150014 · Cited by 223
Magnetic Resonance Imaging Quantification of Liver Iron
Sirlin, C. B., & Reeder, S. B. (2010) · Magnetic Resonance Imaging Clinics of North America · doi:10.1016/j.mric.2010.08.014 · Cited by 215
EASL Clinical Practice Guidelines on haemochromatosis
Zoller, H., Schaefer, B., Vanclooster, A., Griffiths, B., Bardou-Jacquet, E., Corradini, E., Porto, G., Ryan, J., & Cornberg, M. (2022) · Journal of Hepatology · doi:10.1016/j.jhep.2022.03.033 · Cited by 205
“7,36,128 Because of its high prevalence, simplicity, low cost and wide availability, genotyping for the p.C282Y variant in HFE is the fi rst genetic test to be performed in patients with hae-mochromatosis.”
Wullaert, A., van Loo, G., Heyninck, K., & Beyaert, R. (2007) · Endocrine Reviews · doi:10.1210/er.2006-0031 · Cited by 218
MIC Genes: From Genetics to Biology
Bahram, S. (2001) · Advances in Immunology · doi:10.1016/s0065-2776(01)76018-x · Cited by 219
HFE mutations, iron deficiency and overload in 10 500 blood donors
Jackson, H. A., Carter, K., Darke, C., Guttridge, M. G., Ravine, D., Hutton, R. D., Napier, J. A., & Worwood, M. (2001) · British Journal of Haematology · doi:10.1046/j.1365-2141.2001.02949.x · Cited by 218
The MHC, disease and selection
Trowsdale, J. (2011) · Immunology Letters · doi:10.1016/j.imlet.2011.01.002 · Cited by 209
Disease-Related Conditions in Relatives of Patients with Hemochromatosis
Bulaj, Z. J., Ajioka, R. S., Phillips, J. D., LaSalle, B. A., Jorde, L. B., Griffen, L. M., Edwards, C. Q., & Kushner, J. P. (2000) · New England Journal of Medicine · doi:10.1056/nejm200011233432104 · Cited by 222
Burt, M. J., George, P. M., Upton, J. D., Collett, J. A., Frampton, C. M. A., Chapman, T. M., Walmsley, T. A., & Chapman, B. A. (1998) · Gut · doi:10.1136/gut.43.6.830 · Cited by 221
Genomics, Isoforms, Expression, and Phylogeny of the MHC Class I-Related MR1 Gene
Riegert, P., Wanner, V., & Bahram, S. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.8.4066 · Cited by 217
“HFE is yet another example of a drastically divergent MHC-I gene, adjacent to the MHC itself (approximately 4 megabases telomeric to HLA-F) ( 34 ).”
Background(2001) · PubMed
Role of the hypoxia inducible factors HIF in iron metabolism
Peyssonnaux, C., Nizet, V., & Johnson, R. S. (2008) · Cell Cycle · doi:10.4161/cc.7.1.5145 · Cited by 217
Functions of nonclassical MHC and non-MHC-encoded class I molecules
Braud, V. M., Allan, D. S., & McMichael, A. J. (1999) · Current Opinion in Immunology · doi:10.1016/s0952-7915(99)80018-1 · Cited by 217
Luo, X., Kranzler, H. R., Zuo, L., Wang, S., Blumberg, H. P., & Gelernter, J. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi244 · Cited by 214
“However, the peak of the LD distribution might not distinguish reliably among the markers around the putative disease locus when using different LD measures such as the correlation coefficient D, Lewontin’s D0, the robust formulation of the population attributable risk d, Yule’s Q and Kaplan and Weir’s proportional di…”
BackgroundThe iron metabolism of neoplastic cells: Alterations that facilitate proliferation?
Kwok, J. C., & Richardson, D. R. (2002) · Critical Reviews in Oncology/Hematology · doi:10.1016/s1040-8428(01)00213-x · Cited by 215
Association Mapping of Disease Loci, by Use of a Pooled DNA Genomic Screen
Barcellos, L. F., Klitz, W., Field, L. L., Tobias, R., Bowcock, A. M., Wilson, R., Nelson, M. P., Nagatomi, J., & Thomson, G. (1997) · The American Journal of Human Genetics · doi:10.1086/515512 · Cited by 216
Iron Regulation: Macrophages in Control
Sukhbaatar, N., & Weichhart, T. (2018) · Pharmaceuticals · doi:10.3390/ph11040137 · Cited by 200
“The molecular mechanism by which transferrin iron serves as a sensor for hepcidin expression is based on a coordinated interplay between TfR1 and TfR2 with the homeostatic iron regulator HFE, a major histocompatibility complex class I integral membrane protein [65,66].”
BackgroundA survey of 2,851 patients with hemochromatosis:
McDonnell, S. M., Preston, B. L., Jewell, S. A., Barton, J. C., Edwards, C. Q., Adams, P. C., & Yip, R. (1999) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)00120-5 · Cited by 210
HFE Genotype in Patients with Hemochromatosis and Other Liver Diseases
Bacon, B. R., Olynyk, J. K., Brunt, E. M., Britton, R. S., & Wolff, R. K. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-130-12-199906150-00002 · Cited by 214
“Eighty-three percent of 178 typical patients with hemochromatosis were homozygous for one of these mutations (Cys2823Tyr [C282Y]) (3).”
BackgroundInfluentialSelf-citationIn vitro functional analysis of human ferroportin (FPN) and hemochromatosis-associated FPN mutations
Schimanski, L. M., Drakesmith, H., Merryweather-Clarke, A. T., Viprakasit, V., Edwards, J. P., Sweetland, E., Bastin, J. M., Cowley, D., Chinthammitr, Y., Robson, K. J. H., et al. (2005) · Blood · doi:10.1182/blood-2004-11-4502 · Cited by 212
Wallace, D. F., Summerville, L., Crampton, E. M., Frazer, D. M., Anderson, G. J., & Subramaniam, V. N. (2009) · Hepatology · doi:10.1002/hep.23198 · Cited by 209
Alves, F., Lane, D., Nguyen, T. P. M., Bush, A. I., & Ayton, S. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-02088-5 · Cited by 180
Genes that modify the hemochromatosis phenotype in mice
Levy, J. E., Montross, L. K., & Andrews, N. C. (2000) · Journal of Clinical Investigation · doi:10.1172/jci9635 · Cited by 212
“However, there is marked variability in the phenotype of C282Y homozygotes and heterozygotes that is only partially explained by environmental factors.”
InfluentialKato, J., Fujikawa, K., Kanda, M., Fukuda, N., Sasaki, K., Takayama, T., Kobune, M., Takada, K., Takimoto, R., Hamada, H., et al. (2001) · The American Journal of Human Genetics · doi:10.1086/321261 · Cited by 211
“In white populations, 190% of patients with primary iron overload carry a characteristic mutation, C282Y/ H63D, in the hemochromatosis gene (HFE-1) (Feder et al. 1996) or mutation Y250X in the transferrin receptor 2 gene (TFR2, or HFE-3) (Camaschella et al. 2000).”
BackgroundMethodInfluentialPolygenic inheritance, GWAS, polygenic risk scores, and the search for functional variants
Crouch, D. J. M., & Bodmer, W. F. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2005634117 · Cited by 193
The orchestration of body iron intake: how and where do enterocytes receive their cues?
Frazer, D. M., & Anderson, G. J. (2003) · Blood Cells, Molecules, and Diseases · doi:10.1016/s1079-9796(03)00039-1 · Cited by 214
Iron Metabolism: Iron Deficiency and Iron Overload
Andrews, N. C. (2000) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev.genom.1.1.75 · Cited by 215
Adams, E. J., & Luoma, A. M. (2013) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032712-095912 · Cited by 198
Clinical Role of Human Leukocyte Antigen in Health and Disease
Mosaad, Y. M. (2015) · Scandinavian Journal of Immunology · doi:10.1111/sji.12329 · Cited by 208
Bone mineral density in men with genetic hemochromatosis and HFE gene mutation
Guggenbuhl, P., Deugnier, Y., Boisdet, J. F., Rolland, Y., Perdriger, A., Pawlotsky, Y., & Chalès, G. (2005) · Osteoporosis International · doi:10.1007/s00198-005-1934-0 · Cited by 207
“Genetic hemochromatosis (GH) is an autosomal recessive disease mainly due to the C282Y mutation of the HFE gene [1, 2].”
BackgroundMethodHemochromatosis genes and other factors contributing to the pathogenesis of porphyria cutanea tarda
Bulaj, Z. J., Phillips, J. D., Ajioka, R. S., Franklin, M. R., Griffen, L. M., Guinee, D. J., Edwards, C. Q., & Kushner, J. P. (2000) · Blood · doi:10.1182/blood.v95.5.1565.005k42_1565_1571 · Cited by 210
Iron and carcinogenesis: from Fenton reaction to target genes
Toyokuni, S. (2002) · Redox Report · doi:10.1179/135100002125000596 · Cited by 166
Molecular mechanisms involved in intestinal iron absorption
Sharp, P. (2007) · World Journal of Gastroenterology · doi:10.3748/wjg.v13.i35.4716 · Cited by 205
Schmidt, P. J., Toudjarska, I., Sendamarai, A. K., Racie, T., Milstein, S., Bettencourt, B. R., Hettinger, J., Bumcrot, D., & Fleming, M. D. (2013) · Blood · doi:10.1182/blood-2012-09-453977 · Cited by 204
Whitlock, E. P., Garlitz, B. A., Harris, E. L., Beil, T. L., & Smith, P. R. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-145-3-200608010-00009 · Cited by 200
Association between iron overload and osteoporosis in patients with hereditary hemochromatosis
Valenti, L., Varenna, M., Fracanzani, A. L., Rossi, V., Fargion, S., & Sinigaglia, L. (2009) · Osteoporosis International · doi:10.1007/s00198-008-0701-4 · Cited by 203
“Homozygosity for the C282Y mutation of HFE gene involved in iron sensing is responsible for the majority of HHC cases [ 2 ], but geographical differences have been reported and the prevalence of HFE-unrelated HHC is about 30% in southern Europe [3].”
BackgroundCable, R. G., Glynn, S. A., Kiss, J. E., Mast, A. E., Steele, W. R., Murphy, E. L., Wright, D. J., Sacher, R. A., Gottschall, J. L., Vij, V., et al. (2011) · Transfusion · doi:10.1111/j.1537-2995.2010.02865.x · Cited by 197
Roy, C. N., Penny, D. M., Feder, J. N., & Enns, C. A. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.13.9022 · Cited by 206
Self-citationTsukaguchi, H., Sudhakar, A., Le, T. C., Nguyen, T., Yao, J., Schwimmer, J. A., Schachter, A. D., Poch, E., Abreu, P. F., Appel, G. B., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0216242 · Cited by 204
Out of Balance—Systemic Iron Homeostasis in Iron-Related Disorders
Steinbicker, A., & Muckenthaler, M. (2013) · Nutrients · doi:10.3390/nu5083034 · Cited by 195
“Although the gene has already been identified in 1996, the pathophysiology has yet to be understood [56,153].”
BackgroundD’Alessio, F., Hentze, M. W., & Muckenthaler, M. U. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.06.015 · Cited by 200
“The genes encoding HFE [5], hemojuvelin (HJV) [6], transferrin receptor 2 (TfR2) [7] or hepcidin (HAMP) [8] are mutated in different subtypes of the disease.”
BackgroundSmith, B. C., Grove, J., Guzail, M. A., Day, C. P., Daly, A. K., Burt, A. D., & Bassendine, M. F. (1998) · Hepatology · doi:10.1002/hep.510270631 · Cited by 203
Iron refractory iron deficiency anemia
De Falco, L., Sanchez, M., Silvestri, L., Kannengiesser, C., Muckenthaler, M. U., Iolascon, A., Gouya, L., Camaschella, C., & Beaumont, C. (2013) · Haematologica · doi:10.3324/haematol.2012.075515 · Cited by 174
Influence of Iron on Bone Homeostasis
Balogh, E., Paragh, G., & Jeney, V. (2018) · Pharmaceuticals · doi:10.3390/ph11040107 · Cited by 184
“In Caucasian population the most frequent type of hereditary hemochromatosis (HH) is due to a mutation of the HFE gene (Cys282Tyr) [29,30].”
BackgroundHemochromatosis classification: update and recommendations by the BIOIRON Society
Girelli, D., Busti, F., Brissot, P., Cabantchik, I., Muckenthaler, M. U., & Porto, G. (2022) · Blood · doi:10.1182/blood.2021011338 · Cited by 187
Understanding iron homeostasis through genetic analysis of hemochromatosis and related disorders
Camaschella, C. (2005) · Blood · doi:10.1182/blood-2005-05-1857 · Cited by 199
Offenbaecher, M., Bondy, B., Jonge, S. D., Glatzeder, K., Kr�ger, M., Schoeps, P., & Ackenheil, M. (1999) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199911)42:11<2482::aid-anr27>3.0.co;2-b · Cited by 298
Iron homeostasis: An anthropocentric perspective
Coffey, R., & Ganz, T. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.r117.781823 · Cited by 188
High prevalence of the His63Asp HFE mutation in italian patients with porphyria cutanea tarda
Sampietro, M., Piperno, A., Lupica, L., Arosio, C., Vergani, A., Corbetta, N., Malosio, I., Mattioli, M., Fracanzani, A. L., Cappellini, M. D., et al. (1998) · Hepatology · doi:10.1002/hep.510270128 · Cited by 198
The Role of Iron in the Immune Response to Bacterial Infection
Cherayil, B. J. (2011) · Immunologic Research · doi:10.1007/s12026-010-8199-1 · Cited by 191
“The binding of IRPs to the IREs in the 30 untranslated regions of the TfR1 and Nramp2 mRNAs has the effect of stabilizing the transcripts, increasing expression of the proteins and facilitating influx of iron.”
BackgroundInfluentialMorrison, E. D., Brandhagen, D. J., Phatak, P. D., Barton, J. C., Krawitt, E. L., El-Serag, H. B., Gordon, S. C., Galan, M. V., Tung, B. Y., Ioannou, G. N., et al. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-138-8-200304150-00008 · Cited by 191
“The discovery of the hemochromatosis gene, HFE, in 1996 has allowed identification of a genotype (C282Y/ C282Y) that is most likely to lead to clinically significant iron overload (4).”
BackgroundMethodInfluentialHemochromatosis mutations in the general population: iron overload progression rate
Andersen, R. V., Tybjærg-Hansen, A., Appleyard, M., Birgens, H., & Nordestgaard, B. G. (2004) · Blood · doi:10.1182/blood-2003-10-3564 · Cited by 191
A Systems Biology Approach to Iron Metabolism
Chifman, J., Laubenbacher, R., & Torti, S. V. (2014) · Advances in Experimental Medicine and Biology · doi:10.1007/978-1-4939-2095-2_10 · Cited by 167
“The most common and mild form of hereditary hemochromatosis (HH) is due to a missense mutation of the HFE gene, which is incompletely penetrant, and is influenced by environmental and other genetic factors [5,64].”
Iron Chelators in Treatment of Iron Overload
Entezari, S., Haghi, S. M., Norouzkhani, N., Sahebnazar, B., Vosoughian, F., Akbarzadeh, D., Islampanah, M., Naghsh, N., Abbasalizadeh, M., & Deravi, N. (2022) · Journal of Toxicology · doi:10.1155/2022/4911205 · Cited by 171
Regulation of Iron Metabolism by Hepcidin under Conditions of Inflammation
Schmidt, P. J. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.r115.650150 · Cited by 176
“One model asserts that increasing transferrin saturation displaces HFE from TFR1, leading to increased hepcidin expression (37).”
BackgroundInfluentialGenotypic/phenotypic correlations in genetic hemochromatosis: Evolution of diagnostic criteria
Adams, P. C., & Chakrabarti, S. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70483-4 · Cited by 189
Powell, L. W., George, D. K., McDonnell, S. M., & Kowdley, K. V. (1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-129-11_part_2-199812011-00002 · Cited by 186
“For example, as noted above, at the time of discovery of the C282Y mutation of the HFE gene for hemochromatosis, a second mutation, H63D, was found in approximately 4% of patients with hemochromatosis (8).”
BackgroundSun, C. C., Vaja, V., Babitt, J. L., & Lin, H. Y. (2012) · American Journal of Hematology · doi:10.1002/ajh.23110 · Cited by 185
Graham, R. M. (2007) · World Journal of Gastroenterology · doi:10.3748/wjg.v13.i35.4725 · Cited by 177
(2016) · Advances in Clinical Chemistry · doi:10.1016/bs.acc.2016.03.002 · Cited by 177
The Human Major Histocompatibility Complex: Lessons from the DNA Sequence
Beck, S., & Trowsdale, J. (2000) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev.genom.1.1.117 · Cited by 182
Spectrum of hemojuvelin gene mutations in 1q-linked juvenile hemochromatosis
Lanzara, C. (2004) · Blood · doi:10.1182/blood-2004-01-0192 · Cited by 185
Lie, B. A., Todd, J. A., Pociot, F., Nerup, J., Akselsen, H. E., Joner, G., Dahl-Jørgensen, K., Rønningen, K. S., Thorsby, E., & Undlien, D. E. (1999) · The American Journal of Human Genetics · doi:10.1086/302283 · Cited by 182
“Sixteen microsatellite markers (dinucleotide repeats), spanning from ∼2.5 Mb centromeric to ∼8.5 Mb telomeric of the HLA class II region, were selected, mainly from the article by Feder et al. (1996).”
BackgroundMethodInfluentialFleming, R. E., Holden, C. C., Tomatsu, S., Waheed, A., Brunt, E. M., Britton, R. S., Bacon, B. R., Roopenian, D. C., & Sly, W. S. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.051630898 · Cited by 182
Self-citationLebrón, J. A., West, A. P., & Bjorkman, P. J. (1999) · Journal of Molecular Biology · doi:10.1006/jmbi.1999.3252 · Cited by 182
Iron uptake and transport across physiological barriers
Duck, K. A., & Connor, J. R. (2016) · BioMetals · doi:10.1007/s10534-016-9952-2 · Cited by 173
The liver: conductor of systemic iron balance
Meynard, D., Babitt, J. L., & Lin, H. Y. (2014) · Blood · doi:10.1182/blood-2013-06-427757 · Cited by 177
Increased serum ferritin is common in men with essential hypertension
Piperno, A., Trombini, P., Gelosa, M., Mauri, V., Pecci, V., Vergani, A., Salvioni, A., Mariani, R., & Mancia, G. (2002) · Journal of Hypertension · doi:10.1097/00004872-200208000-00013 · Cited by 180
Geissler, C., & Singh, M. (2011) · Nutrients · doi:10.3390/nu3030283 · Cited by 162
“It is an autosomal recessive disease caused mainly by mutation of the gene coding for the HFE protein [27].”
BackgroundMcClain, D. A., Abraham, D., Rogers, J., Brady, R., Gault, P., Ajioka, R., & Kushner, J. P. (2006) · Diabetologia · doi:10.1007/s00125-006-0200-0 · Cited by 179
“Most patients with haemochromatosis are homozygous for a single nucleotide substitution (C282Y) in the haemochromatosis gene (HFE) [3].”
BackgroundKontoghiorghes, G. J., & Kontoghiorghe, C. N. (2016) · Drug Design, Development and Therapy · doi:10.2147/dddt.s79458 · Cited by 174
“Infection, inflammation, and pathological conditions may also influence normal iron metabolism and the rate of iron absorption in IL-NTDT (Table 2).(1,2,5,6,10,11) Dietary habits are also important factors affecting the rate of iron absorption in IL-NTDT patients, but also in normal individuals.”
Assessing the function of genetic variants in candidate gene association studies
Rebbeck, T. R., Spitz, M., & Wu, X. (2004) · Nature Reviews Genetics · doi:10.1038/nrg1403 · Cited by 177
“For example, alleles that are truly causative of a disease state would be expected to be disproportionately over-represented among cases with the disease but under-represented among the disease-free control”
BackgroundIron transport proteins: Gateways of cellular and systemic iron homeostasis
Knutson, M. D. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.r117.786632 · Cited by 165
“On the other end of the spectrum of iron disorders is hereditary hemochromatosis, an autosomal recessive iron-overload disease that results predominantly from a C282Y polymorphism in the HFE (High Fe) gene (5).”
BackgroundIron homeostasis: new tales from the crypt
Roy, C. N., & Enns, C. A. (2000) · Blood · doi:10.1182/blood.v96.13.4020 · Cited by 174
Potential Role of Increased Iron Stores in Diabetes
Wilson, J. G., Maher, J. F., Lindquist, J. H., Grambow, S. C., & Crook, E. D. (2003) · The American Journal of the Medical Sciences · doi:10.1097/00000441-200306000-00004 · Cited by 176
Non-viral causes of hepatocellular carcinoma
Blonski, W. (2010) · World Journal of Gastroenterology · doi:10.3748/wjg.v16.i29.3603 · Cited by 174
The Significance of the 187G (H63D) Mutation in Hemochromatosis
BEUTLER, E., & AUGUST, A. (1997) · The American Journal of Human Genetics · doi:10.1016/s0002-9297(07)64339-0 · Cited by 181
Iron dysregulation in movement disorders
Dusek, P., Jankovic, J., & Le, W. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.12.054 · Cited by 169
Natural history of juvenile haemochromatosis
De Gobbi, M., Roetto, A., Piperno, A., Mariani, R., Alberti, F., Papanikolaou, G., Politou, M., Lockitch, G., Girelli, D., Fargion, S., et al. (2002) · British Journal of Haematology · doi:10.1046/j.1365-2141.2002.03509.x · Cited by 177
Zhang, A.-S., Xiong, S., Tsukamoto, H., & Enns, C. A. (2004) · Blood · doi:10.1182/blood-2003-07-2378 · Cited by 174
Pietrangelo, A. (2016) · Liver International · doi:10.1111/liv.13020 · Cited by 174
“In fact, in 1996, a single gene polymorphism (the 845G–A polymorphism in HFE that results in Cys282YTyr, C282Y, change in HFE protein) was found in patients with hemochromatosis (4).”
BackgroundMechanisms of Iron Accumulation in Hereditary Hemochromatosis
Fleming, R. E., & Sly, W. S. (2002) · Annual Review of Physiology · doi:10.1146/annurev.physiol.64.081501.155838 · Cited by 173
Metadata
- Authors
- Feder, J. N., Gnirke, A., Thomas, W., Tsuchihashi, Z., Ruddy, D. A., Basava, A., Dormishian, F., Domingo, R., Ellis, M. C., Fullan, A., Hinton, L. M., Jones, N. L., Kimmel, B. E., Kronmal, G. S., Lauer, P., Lee, V. K., Loeb, D. B., Mapa, F. A., McClelland, E., Meyer, N. C., Mintier, G. A., Moeller, N., Moore, T., Morikang, E., Prass, C. E., Quintana, L., Starnes, S. M., Schatzman, R. C., Brunke, K. J., Drayna, D. T., Risch, N. J., Bacon, B. R., & Wolff, R. K.
- Affiliations
- Stanford Medicine (US)
- Saint Louis University (US)
- ORCID
- Venue
- Nature Genetics
- Published
- 1996-08
- Volume
- 13
- Issue
- 4
- Pages
- 399-408
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- OpenAlex
- W2002605005
- Cited by
- 3,664
- References
- 78
- Citations by year
- 2026: 27 · 2025: 27 · 2024: 38 · 2023: 47 · 2022: 51 · 2021: 47 · 2020: 67 · 2019: 50 · 2018: 58 · 2017: 92 · 2016: 87 · 2015: 80 · 2014: 74 · 2013: 94 · 2012: 96
- FWCI
- 124.76
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
- Life Sciences › Neuroscience › Neurology › Neurological diseases and metabolism
- Health Sciences › Medicine › Pathology and Forensic Medicine › Genetic factors in colorectal cancer
- Keywords
- hereditary hemochromatosis, HLA-H, HLA-F, missense mutations, iron metabolism, iron accumulation, linkage disequilibrium, haplotype analysis, homozygosity, gene inactivation
- MeSH terms
- Hemochromatosis Protein, Alleles, Amino Acid Sequence, Base Sequence, Chromosomes, Human, Pair 6, Cloning, Molecular, Cysteine, Biological Evolution, Genes, MHC Class I, Genetic Markers, Haplotypes, Hemochromatosis, HLA Antigens, Humans, Major Histocompatibility Complex, Membrane Proteins, Molecular Sequence Data, RNA, Messenger, Histocompatibility Antigens Class I, Linkage Disequilibrium, Gene Expression, Sequence Alignment, Sequence Homology, Amino Acid, DNA Primers, Chromosomes, Artificial, Yeast
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.